Standout Papers
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy (2000)
- Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group (2003)
- Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer (2000)
Immediate Impact
2 by Nobel laureates 14 from Science/Nature 112 standout
Citing Papers
The biology and management of non-small cell lung cancer
2018 StandoutNature
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Works of K. Mattson being referenced
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
2000 Standout
Randomized study of taxotere (TAX) versus best supportive care (BSC) in non-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy
1999
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| K. Mattson | 5464 | 4139 | 1485 | 178 | 7.4k | |
| Mark Vincent | 3660 | 3695 | 1495 | 166 | 6.3k | |
| Jyoti D. Patel | 3353 | 3788 | 1363 | 224 | 5.9k | |
| Philip Bonomi | 4349 | 4803 | 2075 | 240 | 7.8k | |
| Anne S. Tsao | 4164 | 2501 | 1354 | 212 | 6.4k | |
| Makoto Maemondo | 4484 | 4261 | 1827 | 177 | 6.2k | |
| Stephen L. Graziano | 2842 | 2722 | 1236 | 116 | 5.0k | |
| Akira Inoue | 5416 | 4926 | 1727 | 189 | 7.0k | |
| Alan B. Sandler | 3602 | 4405 | 2405 | 107 | 7.4k | |
| Nagio Takigawa | 2849 | 2850 | 1860 | 299 | 5.1k | |
| Alessandro Morabito | 3306 | 4633 | 1629 | 213 | 7.0k |
All Works
Loading papers...